Intel Stock Surges as BofA Projects Strong Growth, Sees $6+ EPS by 2030
BofA boosts Intel to Buy, citing AI agent CPU boom and improved manufacturing outlook.
Already have an account? Sign in.
BofA boosts Intel to Buy, citing AI agent CPU boom and improved manufacturing outlook.
Teradata’s solid Q2 beat on revenue, EPS & cash flow was overshadowed by weak Q3 guidance. ARR grew, but near-term softness sparked a sharp sell-off.
Sight Sciences gets FDA clearance for OMNI Ultra, the first single-pass implant-free MIGS device for glaucoma.
Travere stock jumps as FILSPARI sales surge, beating forecasts and showing strong patient demand and future growth potential.